Hep C in Hawai’i SSPs

Don't get mad...get data!

We are excited to share the 2019 Syringe Exchange Program Annual Report from the Hawai'i Health and Harm Reduction Center, which includes a special section on hepatitis C among people who inject drugs. From the report:

  • 56% of survey participants tested positive for HCV antibodies (HCV Ab).

  • Among those who tested HCV Ab positive, 58% reported never having tested positive for HCV, possibly indicating new exposure or infection.

Read the press release, and download report at https://www.hhhrc.org/sep.

This is more than double the 20% of newly HCV positive in 2016, demonstrating possible increases in HCV transmission among SEP participants in the intervening three years.
— 2019 Syringe Exchange Program Annual Report
Previous
Previous

Hiring Closed-Hep Coordinator

Next
Next

Welcome, Eisai Oncology!